Is There a Difference in Hospital Stay between Patients undergoing Translabyrinthine or Retrosigmoid Surgery for Vestibular Schwannoma Stratified by Tumor Size?

Abstract

Objective To date, no European study has compared approach-specific outcome data in vestibular schwannoma (VS) surgery stratified by tumor size. We analyzed hospital length of stay (LOS), intensive therapy/high-dependency unit (ITU/HDU) LOS, and complications in patients undergoing VS surgery via the translabyrinthine (TL) versus retrosigmoid (RS) approaches, stratifying for tumor size.

Design Prospective database undergoing retrospective review.

Setting Tertiary center.

Participants A total of 117 patients with VS undergoing TL (n = 71) or RS (n = 46) surgical resection from 2011 to 2016 were analyzed. Data including age, gender, surgical approach, tumor size, hospital, and ITU/HDU LOS and postoperative complications were evaluated.

Intervention(s) Therapeutic—VS surgery via either TL or RS approach.

Main Outcome Measure(s) LOS (hospital/intensive care unit).

Results Hospital LOS was significantly greater in patients undergoing the RS approach versus TL approach in VS between 31 and 40 mm (11 versus 7 days, p < 0.0006). The mean ITU/HDU LOS was greater in the RS group compared with the TL group (4.6 versus 1, p > 0.05). Reported complications were higher in the RS group (n = 40 versus 22). A post hoc analysis of the 31 to 40 mm group revealed no statistically significant difference in the American Society of Anesthesiologists grade or preoperative performance status.

Conclusions In our practice, in VS sized 31 to 40 mm patients stay 4 days longer post RS compared with TL surgery. This translates to £1600 extra per patient in the UK. Our data may inform decision-making during the skull base multidisciplinary team and the consent process to help decide the ideal operative approach for the patient.

Keywords

vestibular schwannoma - acoustic neuroma - hospital length of stay - ITU or HDU length of stay - retrosigmoid - translabyrinthine

• References

• 1 Harner SG, Laws Jr ER. Clinical findings in patients with acoustic neurinoma. Mayo Clin Proc 1983; 58 (11) 721-728
• 2 Stangerup SE, Caye-Thomasen P, Tos M, Thomsen J. The natural history of vestibular schwannoma. Otol Neurotol 2006; 27 (04) 547-552
• 3 Hachesu PR, Ahmadi M, Alizadeh S, Sadoughi F. Use of data mining techniques to determine and predict length of stay of cardiac patients. Healthc Inform Res 2013; 19 (02) 121-129
• 4 Cole T, Veeravagu A, Zhang M. , et al. Retrosigmoid versus translabyrinthine approach for acoustic neuroma resection: an assessment of complications and payments in a longitudinal administrative database. Cureus 2015; 7 (10) e369
• 5 Semaan MT, Wick CC, Kinder KJ, Stuyt JG, Chota RL, Megerian CA. Retrosigmoid versus translabyrinthine approach to acoustic neuroma resection: A comparative cost-effectiveness analysis. Laryngoscope 2016; 126 (Suppl. 03) S5-S12
• 6 Department of Health via DATA.GOV.UK statistics. Updated Aug 24, 2015; cited Jul 12, 2017. Available at: https://data.gov.uk/data-request/nhs-hospital-stay
• 7 Ansari SF, Terry C, Cohen-Gadol AA. Surgery for vestibular schwannomas: a systematic review of complications by approach. Neurosurg Focus 2012; 33 (03) E14
• 8 Kim HH, Johnston R, Wiet RJ, Kumar A. Long-term effects of cerebellar retraction in the microsurgical resection of vestibular schwannomas. Laryngoscope 2004; 114 (02) 323-326